Loss of heterozygosity of 3p markers in neuroblastoma tumours
Author Information
Author(s): K Ejeskarl, H Aburatani, J Abrahamsson, P Kogner, T Martinsson
Primary Institution: Gothenburg University, Sahlgrenska University Hospital
Hypothesis
Is there a tumour-suppressor locus distal to the FHIT gene in neuroblastoma?
Conclusion
The study found that neuroblastoma tumours with deletions on chromosome 3p are associated with poor prognosis, while those with complete loss of chromosome 3 have a better outcome.
Supporting Evidence
- 15.3% of tested neuroblastoma tumours showed allelic loss of chromosome 3p markers.
- All children with tumours showing complete loss of chromosome 3 are long-term survivors.
- All children with tumours showing partial 3p LOH have died from tumour progression.
Takeaway
Some children with a type of cancer called neuroblastoma have missing parts of their DNA, and this can make their cancer worse. But if they lose a whole chromosome, they might do better.
Methodology
The study analyzed primary tumour and normal tissue from 59 children with neuroblastoma using PCR-based polymorphic markers to assess loss of heterozygosity.
Limitations
The study is based on a limited sample size and cannot definitively suggest chromosome 3 analysis for individual prognostic evaluation.
Participant Demographics
Children with neuroblastoma of various clinical stages, median age at diagnosis was 14.5 months.
Statistical Information
P-Value
0.0006
Confidence Interval
58.7% ± 6.9%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website